Antidepressant treatments during pregnancy and lactation: prediction of drug exposure through breastfeeding and evaluation of drug effect onthe neonatal adaptation and the development of the young child - SSRI Milk

Hospices Civils de Lyon0 个研究点目标入组 400 人开始时间: 2015年9月15日最近更新: 2015年12月7日

适应症

试验速览

暂无简介。

•-Planning to deliver in the Department of Obstetrics and Gynecology of the Hôpital Mère-Enfants (University Hospital of Lyon) or in the Department of Obstetrics and Gynecology of the University Hospital of Nancy;
•-Under treatment by any SSNR/SSRI (fluvoxamine, fluoxetine, paroxetine, duloxetine, citalopram, escitalopram, sertraline or venlafaxine) without limitation of time since the start of treatment;
•-Who intent to breastfeed their child;
•-Having a health coverage;
•-Without any legal protection measure;
•-Having signed the written informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 180
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•-Mothers <18 years of age patients
•-Inability to communicate due to language problems for the mother,
•-Patients with a socio-economic context making close monitoring of the child by the mother or a relative not possible.

发起方